Amsterdam, The Netherlands and Kansas City, Mo. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its presence at the American Society of Nuclear Cardiology’s Annual Scientific Session in Kansas City, Missouri, from September 14 – 17, 2017. At this year’s session, Philips is highlighting its newest solution for nuclear cardiology, CardioMD IV, a solution leveraging Single Photon Emission Computed Tomography (SPECT) technology, advanced Astonish reconstruction and cardiac quantification software to deliver diagnostic confidence and improved workflow for cardiac imaging.
Recognizing molecular imaging’s unique ability to transform healthcare, CardioMD IV is tailored to address the most pressing challenges in cardiac imaging today. This dedicated cardiac SPECT solution was designed to fit the clinical and economic needs of healthcare institutions. With a small footprint, CardioMD IV will fit in virtually any existing camera room without requiring costly renovations. Its patient-friendly design allows for greater positioning flexibility, and half-time cardiac imaging with Astonish reconstruction improves workflow efficiency without sacrificing image quality. Philips’ advanced visualization and analysis platform, IntelliSpace Portal, provides enterprise-wide access to the latest cardiac SPECT quantification, review and reporting applications while enabling effective collaboration among cardiologists and referring physicians.
“Our aim is to advance molecular imaging in all disease areas, and provide dependable imaging solutions to enhance diagnostic confidence and patient care at lower costs,” said Kirill Shalyaev, Ph.D., Business Leader, Advanced Molecular Imaging, Philips Healthcare. “CardioMD IV delivers the reliable performance and the low total cost of ownership that nuclear cardiology practices need to drive clinical, financial and operational efficiencies.”
Visit the Philips booth #412 for more information about CardioMD IV and Philips’ innovative solutions and services that provide physicians and hospitals the opportunity to deliver advanced cardiovascular care to patients.